Cardiovascular Digital Solutions Market Overview, Analysis And Demand By 2034


Get 20% Off All Market Studies With Code ONLINE20 – Anticipate Tariff Impacts, Market Disruptors, and Long-Term Growth Trends

What Is the Expected Market Growth Rate for the Cardiovascular Digital Solutions Market?
The cardiovascular digital solutions market size has grown strongly in recent years. It will grow from $98.23 billion in 2024 to $107.37 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rise in cardiovascular diseases, telemedicine adoption, data analytics for risk prediction, patient engagement initiatives, remote patient monitoring.

The cardiovascular digital solutions market size is expected to see rapid growth in the next few years. It will grow to $161.27 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to artificial intelligence and machine learning integration, expanding role of digital biomarkers, remote cardiac rehabilitation programs, interoperability of healthcare systems, focus on real-time monitoring and alerts. Major trends in the forecast period include blockchain for secure health data management, integration of EHRS and cardiovascular digital solutions, mobile health apps for cardiovascular management, focus on cardiovascular rehabilitation solutions, collaborations between tech companies and healthcare providers.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9613&type=smp

Which Major Growth Factors Are Shaping the Cardiovascular Digital Solutions Market?
The rise in cardiovascular disease prevalence worldwide is expected to propel the growth of the cardiovascular digital solutions market going forward. Heart and blood vessel problems are referred to as cardiovascular diseases (CVDs). It is a common phrase for diseases that damage the heart or blood vessels. Cardiovascular digital solutions aid in promoting patient autonomy by allowing patients to self-monitor health activities that decrease disease risk factors while encouraging adherence to these lifestyle changes. The use of these solutions decreased the morbidity and mortality of cardiovascular diseases. So, the surge in cases of cardiovascular diseases boosts the market for cardiovascular digital solutions. For instance, in March 2024, according to data published by the Office for Health Improvement and Disparities, a UK-based government department, in 2023 there were just over 1,862,500 people (3%) with a GP diagnosis of coronary heart disease in England. Therefore, the rise in cardiovascular disease prevalence worldwide is driving the cardiovascular digital solutions market.

What Are the Emerging Segments in the Cardiovascular Digital Solutions Market?
The cardiovascular digital solutionsmarket covered in this report is segmented –

1) By Components: Devices, Software
2) By Services: Unobtrusive Testing, CVD Health Informatics, Cardiac Rehab Programs, Other Services
3) By Deployment: Cloud-Based, On-Premise
4) By End-Use: Hospitals And Clinics, Ambulatory Care Centers, Other End-Users

Subsegments:
1) By Devices: Wearable Devices, Implantable Devices, Remote Monitoring Devices
2) By Software: Cardiac Monitoring Software, Data Analytics Platforms, Telehealth Solutions, Patient Management Software

What Are the Top Trends Expected to Shape the Cardiovascular Digital Solutions Market by 2029?
Product innovation is the key trend gaining popularity in the cardiovascular digital solutions market. Major companies operating in the cardiovascular digital solutions market are focused on developing innovative products to strengthen their position in the market. For instance, in February 2023, Eko Health, a US-based manufacturer of digital health solutions for heart and lung disease, launched the SENSORA Cardiac Disease Detection Platform. SENSORA is a cardiovascular disease detection platform that blends the most recent advances in applied machine learning with one of the world's most used medical devices: the stethoscope. Eko has invented a detection platform that might grow as the business creates applications for other cardiac disorders by using its digital stethoscopes to record and analyze electrical signals and heart sounds. SENSORA primarily incorporates AI that reliably recognizes structural murmurs, which indicate heart valve disease, and Care Pathway Analytics software that offers downstream insight and analytics of the care process through the healthcare system.

Which Companies Hold the Largest Share in the Cardiovascular Digital Solutions Market?
Major companies operating in the cardiovascular digital solutions market include iRythm Technologies Inc., Apple Inc., General Electric Company, Uber Diagnostics Private Limited, AlivCor Inc., Verily Life Sciences, HeartFlow Inc., Bardy Diagnostics Inc., BioTelemetry Inc., eviCore healthcare, Nanowear Inc, Cardiac Insight Inc., Bay Labs Solutions, Change Healthcare, Medtronic PLC, BenevolentAI Limited, Cardiologs Technologies, Cardiopulmonary Corp., Congenica Ltd., Cyient Limited, Data4Cure Inc., Deep Genomics Incorporated, DNAnexus Inc., Emedgene Technologies Ltd., Fabric Genomics Inc., FDNA Inc., Freenome Holdings Inc., GNS Healthcare, IBM Watson Health, Illumina Inc., Microsoft Corporation, Niramai Health Analytix, NVIDIA Corporation, Omron Healthcare Co. Ltd.

Get the full cardiovascular digital solutions market report here:
https://www.thebusinessresearchcompany.com/report/cardiovascular-digital-solutions-global-market-report

Which Regions Are Driving the Most Demand in the Cardiovascular Digital Solutions Market?
North America was the largest region in the cardiovascular digital solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the cardiovascular digital solutions market report during the forecast period. The regions covered in the cardiovascular digital solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Scope, Share Analysis And Growth 2025

Image
Focused on real-world business use, this report highlights what’s changing in the hypertrophic cardiomyopathy (hcm) therapeutics market and what companies should prepare for next. What Is The Projected Market Size & Growth Rate Of The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market? The hypertrophic cardiomyopathy (hcm) therapeutics market size has grown marginally in recent years. It will grow from $1.34 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 1.5%. The growth in the historic period can be attributed to diagnostic advancements, increased disease awareness, drug development and approvals, rising healthcare expenditure, government initiatives and funding. The hypertrophic cardiomyopathy (hcm) therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to genetic research and ...
Read more

Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Image
Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the glycomics or glycobiology market. How Big Is The Glycomics or Glycobiology Market In 2025? The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification. The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analy...
Read more

Smart Crop Monitoring Market Overview, Analysis And Demand By 2034

Image
Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the smart crop monitoring sector. How Big Is The Smart Crop Monitoring Market In 2025? The smart crop monitoring market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $4.09 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to rising demand for high crop production, increasing global population, significant growth in IOT technology, rising need for sustainable agricultural practices, and increasing regulatory pressures. The smart crop monitoring market size is expected to see rapid growth in the next few years. It will grow to $7.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to the development of automated irrigation systems, the growing trend of farm-to-table movements, an increase in ag...
Read more